Full history for every metric is available with a Kvantra account
Key financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0.55 | 0.35 | 0.15 | 0.21 | 0.13 | 0.17 | - |
| Operating profit | $m | -0.19 | - | |||||
| Net profit | $m | -0.48 | -0.22 | -0.38 | -0.17 | -0.38 | -0.25 | - |
| EPS reported | $ | -0.00 | - | |||||
| Operating cashflow per share | $ | -0.00 | - | |||||
| Capex per share | $ | 0.00 | - | |||||
| FCF per share | $ | -0.00 | - | |||||
| Free cash flow | $m | -0.29 | - | |||||
| Net debt | $m | -0.17 | - | |||||
| Book value equity | $m | -0.16 | - | |||||
| Book value per share | $ | -0.00 | - | |||||
| Number of shares | m | 126.78 | - | |||||
| DPS (TTM paid) | $ | 0.00 | - |
Financial summary
Financials in USDTTM unavailable| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -7.90 | - | |||||
| P/S LTM | x | 7.49 | - | |||||
| P/FCF LTM | x | -4.34 | - | |||||
| EV/EBITDA LTM | x | -6.06 | - | |||||
| EV/Sales LTM | x | 6.50 | - | |||||
| Earnings Yield LTM | % | -20.30% | - | |||||
| FCF Yield | % | -23.03% | - | |||||
| Quality | ||||||||
| ROE | % | 160.43% | - | |||||
| ROIC | % | 141.38% | - | |||||
| Operating margin | % | -115.12% | - | |||||
| Gross margin | % | -37.37% | - | |||||
| FCF/Sales | % | -172.37% | - | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +25.49% | - | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | - | |||||
| Dividend Growth | % | 0.00% | - | |||||
| Payout Ratio | % | 0.00% | - | |||||
| FCF/Debt | x | -12.96 | - | |||||
| Net Debt/EBITDA | x | 0.92 | - | |||||
| EBIT/Net interest | x | - | - | |||||
| Net debt/market cap | % | -13.15% | - | |||||
| Net debt/Equity | x | 1.04 | - | |||||
| Gross debt/equity | x | -0.14 | - | |||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
LifeQuest World Corporation, operating through its subsidiary entities, specializes in delivering comprehensive solutions for managing and treating both sewage and industrial effluents. The company engineers onsite wastewater treatment systems capable of purifying grey and black water, rendering it fit for reuse in applications like irrigation, toilet flushing, and cleaning. Furthermore, LifeQuest tackles the purification of industrial wastewater across diverse sectors such as textile, tannery, fisheries, dairy, and processed water industries. Among its key offerings is Biopipe, an advanced biological wastewater treatment system deployed in a broad range of settings, including private residences, commercial and multi-unit developments, hotels, hospitals, industrial complexes, and recreational areas. It also provides Abrimix, a water treatment technology versatile enough to process wastewater, processed water, and raw water sources. For water filtration needs, LifeQuest supplies Glanris, a non-toxic filtration media utilized by municipalities, businesses, and individual homeowners and consumers alike. The company also features Goslyn, a grease recovery device specifically engineered to efficiently remove fats, oils, and grease (FOG) from wastewater effluents. Founded in 1997, LifeQuest World Corporation maintains its headquarters in Ridgefield Park, New Jersey.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Not enough data to calculate KvantraRank
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
LifeQuest World Corporation, operating through its subsidiary entities, specializes in delivering comprehensive solutions for managing and treating both sewage and industrial effluents. The company engineers onsite wastewater treatment systems capable of purifying grey and black water, rendering it fit for reuse in applications like irrigation, toilet flushing, and cleaning. Furthermore, LifeQuest tackles the purification of industrial wastewater across diverse sectors such as textile, tannery, fisheries, dairy, and processed water industries. Among its key offerings is Biopipe, an advanced biological wastewater treatment system deployed in a broad range of settings, including private residences, commercial and multi-unit developments, hotels, hospitals, industrial complexes, and recreational areas. It also provides Abrimix, a water treatment technology versatile enough to process wastewater, processed water, and raw water sources. For water filtration needs, LifeQuest supplies Glanris, a non-toxic filtration media utilized by municipalities, businesses, and individual homeowners and consumers alike. The company also features Goslyn, a grease recovery device specifically engineered to efficiently remove fats, oils, and grease (FOG) from wastewater effluents. Founded in 1997, LifeQuest World Corporation maintains its headquarters in Ridgefield Park, New Jersey.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free